E
Oncolytics Biotech Inc. ONCY
$0.9888 -$0.0212-2.10% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 9.18M 9.54M 9.72M 10.03M 11.65M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 22.29M 23.95M 25.55M 26.02M 27.00M
Operating Income -22.29M -23.95M -25.55M -26.02M -27.00M
Income Before Tax -21.75M -22.59M -23.05M -20.21M -20.61M
Income Tax Expenses 86.60K 94.60K 94.60K 109.80K 106.20K
Earnings from Continuing Operations -21.84 -22.69 -23.14 -20.32 -20.72
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -21.84M -22.69M -23.14M -20.32M -20.72M
EBIT -22.29M -23.95M -25.55M -26.02M -27.00M
EBITDA -22.22M -23.88M -25.47M -25.94M -26.93M
EPS Basic -0.27 -0.29 -0.30 -0.27 -0.28
Normalized Basic EPS -0.17 -0.18 -0.19 -0.17 -0.18
EPS Diluted -0.27 -0.29 -0.30 -0.27 -0.28
Normalized Diluted EPS -0.17 -0.18 -0.19 -0.17 -0.18
Average Basic Shares Outstanding 330.22M 315.31M 305.92M 302.15M 294.94M
Average Diluted Shares Outstanding 330.22M 315.31M 305.92M 302.15M 294.94M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --